Anabolic agents and bone quality

Clinical Orthopaedics and Related Research

Volumn 469, Issue 8, 2011, Pages 2215-2224

  Sibai, Tarek ^a   Morgan, Elise F ^b   Einhorn, Thomas A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANABOLIC AGENT; FOCAL ADHESION KINASE 2; GROWTH HORMONE; HYDROXYFASUDIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PF 431386; PITAVASTATIN; PLACEBO; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROTEIN TYROSINE KINASE INHIBITOR; RALOXIFENE; SCLEROSTIN; SIMVASTATIN; SOMATOMEDIN C; STRONTIUM RANELATE; UNCLASSIFIED DRUG;

BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE DYSPLASIA; BONE EXAMINATION; BONE QUALITY; BONE REMODELING; BONE STRENGTH; BONE STRUCTURE; BONE TURNOVER; CALLUS; CARPAL TUNNEL SYNDROME; CONFERENCE PAPER; DIARRHEA; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG SAFETY; EDEMA; ENZYME INHIBITION; FRACTURE; FRAGILITY FRACTURE; GLUCOSE INTOLERANCE; HIP FRACTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; OSTEOSCLEROSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SIDE EFFECT; SUSTAINED DRUG RELEASE; VEIN THROMBOSIS; VERTEBRA FRACTURE; WEIGHT GAIN;

EID: 79960937438     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-010-1722-9     Document Type: Conference Paper

References (83)

1. MP Akhter DM Cullen G Gong RR Recker 2001 Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice Bone. 29 121 125 11502472 10.1016/S8756-3282(01)00486-0 1:CAS:528:DC%2BD3MXlvFWkur8%3D (Pubitemid 32734492)
2. YM Alkhiary LC Gerstenfeld E Krall M Sato M Westmore B Mitlak TA Einhorn 2004 Parathyroid hormone (1-24; teriparatide) enhances experimental fracture healing Trans Orthop Res Soc. 29 328
3. TT Andreassen C Ejersted H Oxlund 1999 Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures J Bone Miner Res. 14 960 968 10352105 10.1359/jbmr.1999.14.6.960 1:CAS:528:DyaK1MXjvFKqurw%3D (Pubitemid 29262891)
4. ME Arlot Y Jiang HK Genant J Zhao B Burt-Pichat JP Roux PD Delmas PJ Meunier 2008 Histomorphometric and μ-CT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate J Bone Miner Res. 23 215 222 17922612 10.1359/jbmr.071012 1:CAS:528:DC%2BD1cXhvVOhtr8%3D (Pubitemid 351160035)
5. P Aspenberg HK Genant T Johansson AJ Nino K See K Krohn PA García-Hernández CP Recknor TA Einhorn GP Dalsky BH Mitlak A Fierlinger MC Lakshmanan 2010 Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures J Bone Miner Res. 25 404 414 19594305 10.1359/jbmr.090731 1:CAS:528:DC%2BC3cXksl2ksLg%3D
6. Aubin J, Triffitt J. Mesenchymal stem cells and osteoblast differentiation. In: Bilezikian J, Raisz L, Rodan G, eds. Principles of Bone Biology. San Diego, CA: Academic Press; 2002: 59-82.
7. SD Bain C Jerome V Shen I Dupin-Roger P Ammann 2009 Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants Osteoporos Int. 20 1417 1428 19096745 10.1007/s00198-008-0815-8 1:CAS:528:DC%2BD1MXotlyhurg%3D
8. W Balemans M Ebeling N Patel E Van Hul P Olson M Dioszegi C Lacza W Wuyts J Van Den Ende P Willems AF Paes-Alves S Hill M Bueno FJ Ramos P Tacconi FG Dikkers C Stratakis K Lindpaintner B Vickery D Foernzler W Van Hul 2001 Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) Hum Mol Genet. 10 537 543 11181578 10.1093/hmg/10.5.537 1:CAS:528:DC%2BD3MXhslSitbw%3D (Pubitemid 32184286)
9. R Baron Y Tsouderos 2002 In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation Eur J Pharmacol. 450 11 17 12176103 10.1016/S0014-2999(02)02040-X 1:CAS:528:DC%2BD38XmtlKjsb8%3D
10. DC Bauer GR Mundy SA Jamal DM Black JA Cauley KE Ensrud M Van Der Klift H Pols 2004 Use of statins and fracture results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials Arch Intern Med. 164 146 152 14744837 10.1001/archinte.164.2.146 1:CAS:528: DC%2BD2cXhsFWhsLo%3D (Pubitemid 38140400)
11. DS Benoit CR Nuttelman SD Collins KS Anseth 2006 Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration Biomaterials. 27 6102 6110 16860387 10.1016/j.biomaterials.2006.06.031 1:CAS:528:DC%2BD28XpvVOlsLg%3D (Pubitemid 44414974)
12. GM Blake I Fogelman 2007 The correction of BMD measurements for bone strontium content J Clin Densitom. 10 259 265 17543560 10.1016/j.jocd.2007.03. 102 (Pubitemid 47198528)
13. ML Bouxsein 2003 Bone quality: where do we go from here? Osteoporos Int 14 Suppl 5 S118 S127 14504716 10.1007/s00198-003-1489-x
14. ML Bouxsein P Chen EV Glass DF Kallmes PD Delmas BH Mitlak 2009 Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis: results from two randomized controlled trials J Bone Joint Surg Am. 91 1329 1338 19487509 10.2106/JBJS.H.01030
15. L Buckbinder DT Crawford H Qi HZ Ke LM Olson KR Long PC Bonnette AP Baumann JE Hambor WA Grasser 3rd LC Pan TA Owen MJ Luzzio CA Hulford DF Gebhard VM Paralkar HA Simmons JC Kath WG Roberts SL Smock A Guzman-Perez TA Brown M Li 2007 Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis Proc Natl Acad Sci USA. 104 10619 10624 17537919 10.1073/pnas.0701421104 1:CAS:528:DC%2BD2sXnt1Ohtro%3D (Pubitemid 47185714)
16. J Buehler P Chappuis JL Saffar Y Tsouderos A Vignery 2001 Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis) Bone. 29 176 179 11502480 10.1016/S8756-3282(01)00484-7 1:CAS:528:DC%2BD3MXlvFWkurg%3D (Pubitemid 32734498)
17. DB Burr T Hirano CH Turner C Hotchkiss R Brommage JM Hock 2001 Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys J Bone Miner Res. 16 157 165 11149480 10.1359/jbmr.2001.16.1.157 1:CAS:528:DC%2BD3MXitlCgsQ%3D%3D (Pubitemid 32046201)
18. E Canalis A Giustina JP Bilezikian 2007 Mechanisms of anabolic therapies for osteoporosis N Engl J Med. 357 905 916 17761594 10.1056/NEJMra067395 1:CAS:528:DC%2BD2sXpvVylurk%3D (Pubitemid 47347324)
19. E Canalis M Hott P Deloffre Y Tsouderos PJ Marie 1996 The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro Bone. 18 517 523 8805991 10.1016/8756-3282(96)00080-4 1:CAS:528: DyaK28Xkslagu7k%3D (Pubitemid 26257871)
20. M Degerblad BA Bengtsson M Bramnert O Johnell P Manhem T Rosen M Thoren 1995 Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy Eur J Endocrinol. 133 180 188 7655642 10.1530/eje.0.1330180 1:CAS:528: DyaK2MXnsFGjsbg%3D
21. DW Dempster F Dosman M Parisien V Shen R Lindsay 1993 Anabolic actions of parathyroid hormone on bone Endocr Rev. 14 690 709 8119233 1:CAS:528: DyaK2cXmvFKlug%3D%3D (Pubitemid 24016657)
22. H Dobnig JJ Stepan DB Burr J Li D Michalská A Sipos H Petto A Fahrleitner-Pammer I Pavo 2009 Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate J Bone Miner Res. 24 1998 2006 19453263 10.1359/jbmr.090527 1:CAS:528: DC%2BC3cXht1Wnsrc%3D
23. H Dobnig RT Turner 1995 Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells Endocrinology. 136 3632 3638 7628403 10.1210/en.136.8.3632 1:CAS:528:DyaK2MXntFKntbs%3D
24. Edward B, Juppner H. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 6th ed. Washington, DC: American Society of Bone and Mineral Research; 2006:90-93.
25. CJ Edwards DJ Hart TD Spector 2000 Oral statins and increased bone mineral density in postmenopausal women Lancet. 355 2218 2219 10881898 10.1016/S0140-6736(00)02408-9 1:CAS:528:DC%2BD3cXltVCnt78%3D (Pubitemid 30394332)
26. Finklestein JS. Pharmacological mechanisms of therapeutics; parathyroid hormone. In: Bielzikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. New York, NY: Academic Press; 1996: 993-1005.
27. IR Garrett GE Gutierrez G Rossini J Nyman B McCluskey A Flores GR Mundy 2007 Locally delivered lovastatin nanoparticles enhance fracture healing in rats J Orthop Res. 25 1351 1357 17506505 10.1002/jor.20391 1:CAS:528: DC%2BD2sXhtFyjs7%2FO (Pubitemid 47523365)
28. E Gazzerro E Canalis 2006 Skeletal actions of insulin-like growth factors Expert Rev Endocrinol Metab. 1 47 56 10.1586/17446651.1.1.47 1:CAS:528:DC%2BD28XjtFens7Y%3D
29. LJ Ghiron JL Thompson L Holloway RL Hintz GE Butterfield AR Hoffman R Marcus 1995 Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women J Bone Miner Res. 10 1844 1852 8619364 10.1002/jbmr.5650101203 1:CAS:528:DyaK28XmvFantg%3D%3D
30. A Giustina G Mazziotti E Canalis 2008 Growth hormone, insulin-like growth factors, and the skeleton Endocr Rev. 29 535 559 18436706 10.1210/er.2007-0036 1:CAS:528:DC%2BD1cXhtVKnsrvL
31. GE Gutierrez JR Edwards IR Garrett JS Nyman B McCluskey G Rossini A Flores DB Neidre GR Mundy 2008 Transdermal lovastatin enhances fracture repair in rats J Bone Miner Res. 23 1722 1730 18597639 10.1359/jbmr.080603 1:CAS:528:DC%2BD1cXhtlGlu7zI
32. GE Gutierrez D Lalka IR Garrett G Rossini GR Mundy 2006 Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations Osteoporos Int. 17 1033 1042 16758140 10.1007/s00198-006-0079-0 1:CAS:528:DC%2BD28XltlOju7g%3D (Pubitemid 43869919)
33. B Habermann K Kafchitsas G Olender P Augat A Kurth 2010 Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing Calcif Tissue Int. 86 82 89 19960189 10.1007/s00223-009-9317-8 1:CAS:528:DC%2BC3cXit1Knsw%3D%3D
34. JM Hock 1999 Stemming bone loss by suppressing apoptosis J Clin Invest. 104 371 373 10449428 10.1172/JCI7991 1:CAS:528:DyaK1MXltlektb0%3D (Pubitemid 29534320)
35. AB Hodsman DA Hanley MP Ettinger MA Bolognese J Fox AJ Metcalfe R Lindsay 2003 Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis J Clin Endocrinol Metab. 88 5212 5220 14602752 10.1210/jc.2003-030768 1:CAS:528:DC%2BD3sXptVyns7k%3D (Pubitemid 37452718)
36. G Holzer RJ Majeska MW Lundy JR Hartke TA Einhorn 1999 Parathyroid hormone enhances fracture healing: a preliminary report Clin Orthop Relat Res. 366 258 263 10627743 10.1097/00003086-199909000-00033 (Pubitemid 29439363)
37. WS Jee YF Ma 1997 The in vivo anabolic actions of prostaglandins in bone Bone. 21 297 304 9315332 10.1016/S8756-3282(97)00147-6 1:CAS:528: DyaK2sXnt1KmsrY%3D (Pubitemid 27454082)
38. Y Jiang JJ Zhao BH Mitlak O Wang HK Genant EF Eriksen 2003 Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure J Bone Miner Res. 18 1932 1941 14606504 10.1359/jbmr.2003.18.11.1932 1:CAS:528:DC%2BD3sXptVyiu74%3D (Pubitemid 37377441)
39. RL Jilka RS Weinstein T Bellido P Roberson AM Parfitt SC Manolagas 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone J Clin Invest. 104 439 446 10449436 10.1172/JCI6610 1:CAS:528: DyaK1MXltlekur8%3D (Pubitemid 29534328)
40. Juppner H, Gardella T, Brown E, Kronenberg H, Potts J Jr. (2005) Parathyroid hormone and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development. In: DeGroot L, Jameson J, eds. Endocrinology. Philadelphia, PA: Saunders. 1377-1417.
41. S Kakar TA Einhorn S Vora LJ Miara G Hon NA Wigner D Toben KA Jacobsen MO Al-Sebaei M Song PC Trackman EF Morgan LC Gerstenfeld GL Barnes 2007 Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures J Bone Miner Res. 22 1903 1912 17680724 10.1359/jbmr.070724 1:CAS:528:DC%2BD2sXhsVyjtrnO (Pubitemid 351229307)
42. HZ Ke DT Crawford H Qi HA Simmons TA Owen VM Paralkar M Mei Li B Lu WA Grasser KO Cameron BA Lefker P DaSilva-Jardine DO Scott Q Zhang XY Tian WS Jee TA Brown DD Thompson 2006 A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats J Bone Miner Res. 21 565 575 16598377 10.1359/jbmr.051110 1:CAS:528: DC%2BD28Xkt1Kqs78%3D
43. HZ Ke V Shen H Qi DT Crawford DD Wu XG Liang KL Chidsey-Frink CM Pirie HA Simmons DD Thompson 1998 Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia Bone. 23 249 255 9737347 10.1016/S8756-3282(98)00102-1 1:CAS:528:DyaK1cXlvF2hurg%3D (Pubitemid 28434669)
44. M Kneissel A Boyde JA Gasser 2001 Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34) Bone. 28 237 250 11248653 10.1016/S8756-3282(00)00448-8 1:CAS:528:DC%2BD3MXhvVamsbo%3D (Pubitemid 32192948)
45. S Komatsubara S Mori T Mashiba K Nonaka A Seki T Akiyama K Miyamoto Y Cao T Manabe H Norimatsu 2005 Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora Bone. 36 678 687 15781006 10.1016/j.bone.2005.02. 002 1:CAS:528:DC%2BD2MXjs1Krur8%3D (Pubitemid 40602261)
46. JA Langlois CJ Rosen M Visser MT Hannan T Harris PW Wilson DP Kiel 1998 Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study J Clin Endocrinol Metab. 83 4257 4262 9851760 10.1210/jc.83.12.4257 1:CAS:528:DyaK1cXnvFOrtrc%3D (Pubitemid 29100118)
47. J Li I Sarosi RC Cattley J Pretorius F Asuncion M Grisanti S Morony S Adamu Z Geng W Qiu P Kostenuik DL Lacey WS Simonet B Bolon X Qian V Shalhoub MS Ominsky H Zhu Ke X Li WG Richards 2006 Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia Bone. 39 754 766 16730481 10.1016/j.bone.2006.03. 017 1:CAS:528:DC%2BD28XpsVOhtL4%3D (Pubitemid 44311706)
48. M Li HZ Ke H Qi DR Healy Y Li DT Crawford VM Paralkar TA Owen KO Cameron BA Lefker TA Brown DD Thompson 2003 A novel, nonprostanoid EP2 receptor selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing J Bone Miner Res. 18 2033 2042 14606517 10.1359/jbmr.2003.18. 11.2033 1:CAS:528:DC%2BD3sXptVyiu7o%3D (Pubitemid 37377454)
49. M Li DD Thompson VM Paralkar 2007 Prostaglandin E2 receptors in bone formation Int Orthop. 31 767 772 17593365 10.1007/s00264-007-0406-x 1:STN:280:DC%2BD2snnsVaktQ%3D%3D (Pubitemid 350160307)
50. X Li MS Ominsky KS Warmington S Morony J Gong J Cao Y Gao V Shalhoub B Tipton R Haldankar Q Chen A Winters T Boone Z Geng QT Niu HZ Ke PJ Kostenuik WS Simonet DL Lacey C Paszty 2009 Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis J Bone Miner Res. 24 578 588 19049336 10.1359/jbmr.081206 1:CAS:528:DC%2BD1MXksF2lu7c%3D
51. X Li Y Zhang H Kang W Liu P Liu J Zhang SE Harris D Wu 2005 Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling J Biol Chem. 280 19883 19887 15778503 10.1074/jbc.M413274200 1:CAS:528:DC%2BD2MXktFylsbs%3D (Pubitemid 41379516)
52. C Lin X Jiang Z Dai X Guo T Weng J Wang Y Li G Feng X Gao L He 2009 Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/b-catenin signaling J Bone Miner Res. 24 1651 1661 19419300 10.1359/jbmr.090411 1:CAS:528:DC%2BD1MXhtlGgurbF
53. YF Ma XJ Li WS Jee J McOsker XG Liang R Setterberg SY Chow 1995 Effects of prostaglandin E2 and F2 on the skeleton of osteopenic ovariectomized rats Bone. 17 549 554 8835309 10.1016/8756-3282(95)00387-8 1:CAS:528: DyaK28XlvF2jtQ%3D%3D (Pubitemid 26017576)
54. M Machwate S Harada CT Leu G Seedor M Labelle M Gallant S Hutchins N Lachance N Sawyer D Slipetz KM Metters SB Rodan R Young GA Rodan 2001 Prostaglandin receptor EP4 mediates the bone anabolic effects of PGE2 Mol Pharmacol. 60 36 41 11408598 1:CAS:528:DC%2BD3MXks1Crt7g%3D (Pubitemid 32595231)
55. SC Manolagas 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis Endocr Rev. 21 115 137 10782361 10.1210/er.21.2.115 1:STN:280: DC%2BD3c3ksVaiug%3D%3D (Pubitemid 32275592)
56. PJ Marie 2006 Strontium ranelate: a physiological approach for optimizing bone formation and resorption Bone 38 Suppl 1 S10 S14 16439191 10.1016/j.bone.2005.07.029 1:CAS:528:DC%2BD28XhtlartL8%3D (Pubitemid 43190768)
57. G Mazziotti A Bianchi S Bonadonna M Nuzzo V Cimino A Fusco L De Marinis A Giustina 2006 Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy J Bone Miner Res. 21 520 528 16598371 10.1359/jbmr.060112 1:CAS:528:DC%2BD28Xkt1Kqsrk%3D
58. PJ Meunier C Roux S Ortolani M Diaz-Curiel J Compston P Marquis C Cormier G Isaia J Badurski JD Wark J Collette JY Reginster 2009 Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial Osteoporos Int. 20 1663 1673 19153678 10.1007/s00198-008-0825-6 1:CAS:528:DC%2BD1MXhtVygt7zI
59. PJ Meunier C Roux E Seeman S Ortolani JE Badurski TD Spector J Cannata A Balogh EM Lemmel S Pors-Nielsen R Rizzoli HK Genant JY Reginster 2004 The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med. 350 459 468 14749454 10.1056/NEJMoa022436 1:CAS:528:DC%2BD2cXos1Snsw%3D%3D (Pubitemid 38133766)
60. G Mundy R Garrett S Harris J Chan D Chen G Rossini B Boyce M Zhao G Gutierrez 1999 Stimulation of bone formation in vitro and in rodents by statins Science. 286 1946 1949 10583956 10.1126/science.286.5446.1946 1:CAS:528:DyaK1MXnvFSiu78%3D (Pubitemid 129515901)
61. Mundy GR, Roodman GD, eds. Osteoclast Ontogeny and Function. Amsterdam, The Netherlands: Elsevier; 1987.
62. A Nakajima N Shimoji K Shiomi S Shimizu H Moriya TA Einhorn M Yamazaki 2002 Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34) J Bone Miner Res. 17 2038 2047 12412812 10.1359/jbmr.2002.17.11.2038 1:CAS:528:DC%2BD38Xoslems7k%3D (Pubitemid 35239205)
63. RM Neer CD Arnaud JR Zanchetta R Prince GA Gaich JY Reginster AB Hodsman EF Eriksen S Ish-Shalom HK Genant O Wang BH Mitlak 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med. 344 1434 1441 11346808 10.1056/ NEJM200105103441904 1:CAS:528:DC%2BD3MXktVSgsbw%3D (Pubitemid 32402100)
64. BW Nelson 2002 Bone quality: getting closer to a definition J Bone Miner Res. 17 1148 1150 10.1359/jbmr.2002.17.7.1148
65. K Ohnaka S Shimoda H Nawata H Shimokawa K Kaibuchi Y Iwamoto R Takayanagi 2001 Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of rho-associated kinase in human osteoblasts Biochem Biophys Res Commun. 287 337 342 11554731 10.1006/bbrc.2001.5597 1:CAS:528:DC%2BD3MXms12rtb4%3D (Pubitemid 32917601)
66. H Oxlund M Dalstra TT Andreassen 2001 Statin given perorally to adult rats increases cancellous bone mass and compressive strength Calcif Tissue Int. 69 299 304 11768201 10.1007/s00223-001-2027-5 1:CAS:528:DC%2BD38XhtFOmtQ%3D%3D (Pubitemid 33140941)
67. KE Poole RL van Bezooijen N Loveridge H Hamersma SE Papapoulos CW Lowik J Reeve 2005 Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation FASEB J. 19 1842 1844 16123173 1:CAS:528:DC%2BD2MXht1emsbrP (Pubitemid 41598769)
68. LG Raisz FN Woodiel 2003 Effects of selective prostaglandin EP2 and EP4 receptor agonists on bone resorption and formation in fetal rat organ cultures Prostaglandin Other Lipid Mediat. 71 287 292 10.1016/S1098-8823(03)00049-2 1:CAS:528:DC%2BD3sXlvFOrsbk%3D (Pubitemid 36929797)
69. JY Reginster D Felsenberg S Boonen A Diez-Perez R Rizzoli ML Brandi TD Spector K Brixen S Goemaere C Cormier A Balogh PD Delmas PJ Meunier 2008 Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial Arthritis Rheum. 58 1687 1695 18512789 10.1002/art.23461 1:CAS:528:DC%2BD1cXotVOntrg%3D (Pubitemid 351847521)
70. BL Riggs AP Michael 2005 Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling J Bone Miner Res. 20 177 183 15647810 10.1359/JBMR.041114 1:CAS:528: DC%2BD2MXhsFarsr8%3D
71. KG Saag JR Zanchetta JP Devogelaer RA Adler R Eastell K See JH Krege K Krohn MR Warner 2009 Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial Arthritis Rheum. 60 3346 3355 19877063 10.1002/art.24879 1:CAS:528:DC%2BD1MXhsFentLzO
72. SK Saraf A Singh RS Garbyal V Singh 2007 Effect of simvastatin on fracture healing-an experimental study Indian J Exp Biol. 45 444 449 17569286 1:CAS:528:DC%2BD2sXmtl2nt7w%3D
73. M Sato M Westmore YL Ma A Schmidt QQ Zeng EV Glass J Vahle R Brommage CP Jerome CH Turner 2004 Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity J Bone Miner Res. 19 623 629 15005850 10.1359/JBMR.040112 1:CAS:528:DC%2BD2cXjt1Gqt7o%3D (Pubitemid 41071223)
74. A Schneider LM Kalikin AC Mattos ET Keller MJ Allen KJ Pienta LK McCauley 2005 Bone turnover mediates preferential localization of prostate cancer in the skeleton Endocrinology. 146 1727 1736 15637291 10.1210/en.2004-1211 1:CAS:528:DC%2BD2MXis1yqtL8%3D (Pubitemid 40396881)
75. B Skoglund C Forslund P Aspenberg 2002 Simvastatin improves fracture healing in mice J Bone Miner Res. 17 2004 2008 12412808 10.1359/jbmr.2002.17.11. 2004 1:CAS:528:DC%2BD38Xoslems7s%3D (Pubitemid 35239202)
76. AH Tashjian Jr RF Gagel 2006 Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis J Bone Miner Res 21 354 436 16491282 10.1359/JBMR.051023 1:CAS:528: DC%2BD28XisFGqtbc%3D
77. K Ueda A Saito H Nakano M Aoshima M Yokota R Muraoka T Iwaya 1980 Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease J Pediatr. 97 834 836 7000997 10.1016/S0022-3476(80)80282-4 1:STN:280:DyaL3M%2FkvFSjsg%3D%3D (Pubitemid 11216861)
78. M Weinreb A Grosskopf N Shir 1999 The anabolic effect of PGE2 in rat bone marrow cultures is mediated via EP4 receptor subtype Am J Physiol. 276 E376 E383 9950799 1:CAS:528:DyaK1MXht12hsr4%3D
79. JF Whitfield P Morley G Willick R Langille V Ross S MacLean JR Barbier 1997 Cyclization by a specific lactam increases the ability of human parathyroid hormone (hPTH)-(1-31)NH2 to stimulate bone growth in ovariectomized rats J Bone Miner Res. 12 1246 1252 9258755 10.1359/jbmr.1997.12.8.1246 1:CAS:528:DyaK2sXlsVOktLY%3D (Pubitemid 27334971)
80. C Wuster R Abs BA Bengtsson H Bennmarker U Feldt-Rasmussen E Hernberg-Stahl JP Monson B Westberg P Wilson KIMS Study Group and the KIMS International Board 2001 The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density J Bone Miner Res. 16 398 405 11204440 10.1359/jbmr.2001.16.2.398 1:CAS:528:DC%2BD3MXptlyjtg%3D%3D (Pubitemid 32106717)
81. VK Yadav JH Ryu N Suda KF Tanaka JA Gingrich G Schütz FH Glorieux CY Chiang JD Zajac KL Insogna JJ Mann R Hen P Ducy G Karsenty 2008 Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum Cell. 135 825 837 19041748 10.1016/j.cell.2008.09.059 1:CAS:528:DC%2BD1cXhsV2jtr%2FP
82. RS Yang TK Liu SY Lin-Shiau 1993 Increased bone growth by local prostaglandin E2 in rat Calcif Tissue Int. 52 57 61 8453506 10.1007/BF00675627 1:CAS:528:DyaK3sXit1Kns7k%3D
83. FL Zhang PJ Casey 1996 Protein prenylation: molecular mechanisms and functional consequences Annu Rev Biochem. 65 241 269 8811180 10.1146/annurev.bi.65.070196.001325 1:CAS:528:DyaK28XktFamtL0%3D (Pubitemid 26250610)